085 - Navigating the Demand Revolution in Sustainable Healthcare with Nicolai Broby Eckert
The Sustainable Healthcare PodcastShow Notes
Commercializing Sustainability in Healthcare: Insights from 'The Demand Revolution'
In this episode of the Sustainable Healthcare Podcast, host Joachim interviews Nicolai Broby Eckert, a senior partner at Simon-Kucher and author of 'The Demand Revolution'.
They discuss the challenges and opportunities in commercializing sustainability in pharma, MedTech, and healthcare sectors. Nicolai shares key insights from his book, including:
- The importance of affordable green products - 85% of consumers are on a sustainability journey - you should segment based on this - Strategic plays companies can adopt to integrate sustainability into their business models.
00:00 Intro 00:11 Meet Our Guest: Nikolai, Author of 'The Demand Revolution' 00:57 The Disconnect Between CEOs and Consumers on Sustainability 02:56 Consumer Behavior and Sustainability: Key Findings 07:35 Strategic Implications for Companies 10:42 Sustainability in Pharma and MedTech 16:42 The Importance of Partnerships and Stakeholder Engagement 21:03 The Kodak Moment: Risks and Opportunities 25:35 Innovative Strategies for Sustainability 33:43 Final Thoughts and Where to Find More Information
More from The Sustainable Healthcare Podcast
Most work on greener medication starts with the waste bin. This episode goes one step upstream, to the moment a medicine is prescribed at all, and in which form. Lisa-Marie Smale and Nicole Hunfeld explain what 63 Dutch doctors and pharmacists agreed to change about prescribing, why a tablet can beat a drip, and where a stop date gets lost on the way home.
Hospitals use many single-use products.
What happens when you move acute hospital care into the patient's own home? Maria Normand Larsen shares the results of Denmark's first hospital-at-home randomised trial.
If we want to fix sustainability in healthcare, one of the most powerful levers sits at the gate where new health technologies get approved: Health Technology Assessment (HTA).
How do you cut 40% of the carbon out of a clinical trial without changing the price? You rent the equipment instead of buying it.